1.
Ziakas PD. Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain. Haematologica [Internet]. 2008Aug.29 [cited 2026Nov.16];93(9):1412-4. Available from: https://haematologica.org/article/view/5008